Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZZ) Current Assets (2021 - 2025)

Historic Current Assets for Core Scientific (CORZZ) over the last 5 years, with Q3 2025 value amounting to $1.1 billion.

  • Core Scientific's Current Assets rose 28186.43% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 28186.43%. This contributed to the annual value of $904.0 million for FY2024, which is 83176.59% up from last year.
  • Core Scientific's Current Assets amounted to $1.1 billion in Q3 2025, which was up 28186.43% from $1.0 billion recorded in Q2 2025.
  • Core Scientific's Current Assets' 5-year high stood at $1.1 billion during Q3 2025, with a 5-year trough of $2.0 million in Q3 2021.
  • Over the past 5 years, Core Scientific's median Current Assets value was $143.3 million (recorded in 2024), while the average stood at $377.2 million.
  • Data for Core Scientific's Current Assets shows a peak YoY increase of 2948072.16% (in 2022) and a maximum YoY decrease of 8875.15% (in 2022) over the last 5 years.
  • Core Scientific's Current Assets (Quarter) stood at $756.6 million in 2021, then plummeted by 88.75% to $85.1 million in 2022, then increased by 14.0% to $97.0 million in 2023, then surged by 831.77% to $904.0 million in 2024, then grew by 17.38% to $1.1 billion in 2025.
  • Its Current Assets stands at $1.1 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $833.2 million for Q1 2025.